LCS
Levin Capital Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-847
| Closed | -$356K | – | 234 |
|
|
2022
Q4 | $356K | Buy |
+847
| New | +$356K | 0.05% | 142 |
|
|
2022
Q2 | – | Sell |
-500
| Closed | -$282K | – | 255 |
|
|
2022
Q1 | $282K | Buy |
+500
| New | +$282K | 0.03% | 195 |
|
|
2019
Q1 | – | Sell |
-569,205
| Closed | -$132M | – | 199 |
|
|
2018
Q4 | $132M | Buy |
569,205
+561,328
| +7,126% | +$130M | 2.91% | 11 |
|
|
2018
Q3 | $2.47M | Buy |
7,877
+3,414
| +76% | +$1.07M | 0.04% | 94 |
|
|
2018
Q2 | $1.29M | Sell |
4,463
-9,179
| -67% | -$2.65M | 0.02% | 122 |
|
|
2018
Q1 | $3.41M | Buy |
+13,642
| New | +$3.41M | 0.06% | 91 |
|
|
2017
Q1 | – | Sell |
-267,619
| Closed | -$48.8M | – | 309 |
|
|
2016
Q4 | $48.8M | Sell |
267,619
-110,893
| -29% | -$20.2M | 0.84% | 35 |
|
|
2016
Q3 | $62K | Sell |
378,512
-417,550
| -52% | -$68.4K | 0.91% | 28 |
|
|
2016
Q2 | $114M | Buy |
796,062
+33,600
| +4% | +$4.81M | 2.05% | 14 |
|
|
2016
Q1 | $104M | Buy |
762,462
+73,248
| +11% | +$10M | 1.89% | 17 |
|
|
2015
Q4 | $95.6M | Buy |
689,214
+60,059
| +10% | +$8.33M | 1.68% | 19 |
|
|
2015
Q3 | $84.5M | Sell |
629,155
-27,051
| -4% | -$3.63M | 1.44% | 24 |
|
|
2015
Q2 | $98.8M | Buy |
656,206
+249,275
| +61% | +$37.5M | 1.46% | 26 |
|
|
2015
Q1 | $55M | Sell |
406,931
-429,796
| -51% | -$58.1M | 0.82% | 35 |
|
|
2014
Q4 | $101M | Sell |
836,727
-196,154
| -19% | -$23.6M | 1.52% | 20 |
|
|
2014
Q3 | $117M | Buy |
1,032,881
+79,080
| +8% | +$8.97M | 1.78% | 14 |
|
|
2014
Q2 | $114M | Sell |
953,801
-2,068
| -0.2% | -$248K | 1.76% | 16 |
|
|
2014
Q1 | $122M | Buy |
955,869
+152,963
| +19% | +$19.6M | 2.05% | 15 |
|
|
2013
Q4 | $99.2M | Sell |
802,906
-61,328
| -7% | -$7.58M | 1.6% | 22 |
|
|
2013
Q3 | $102M | Buy |
864,234
+127,355
| +17% | +$15M | 1.73% | 19 |
|
|
2013
Q2 | $82.7M | Buy |
+736,879
| New | +$82.7M | 1.49% | 21 |
|